In 2020 Vacchi and colleagues [150] developed a diagnostic protocol able to differentially diagnose people affected by PD, MSA, atypical parkinsonism with tauopathies (AP tau) vs. HC. The gene discussed is MAPT; the disease is Parkinson disease.